Quantbot Technologies LP Takes Position in Trupanion, Inc. (NASDAQ:TRUP)

Quantbot Technologies LP acquired a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 31,103 shares of the financial services provider's stock, valued at approximately $1,499,000. Quantbot Technologies LP owned about 0.07% of Trupanion as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Wellington Management Group LLP boosted its holdings in shares of Trupanion by 4.4% in the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider's stock worth $142,475,000 after acquiring an additional 142,156 shares in the last quarter. FMR LLC increased its holdings in Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock valued at $49,213,000 after purchasing an additional 1,170,202 shares during the last quarter. Baillie Gifford & Co. increased its holdings in Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after purchasing an additional 147,341 shares during the last quarter. DF Dent & Co. Inc. lifted its stake in Trupanion by 27.8% in the third quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider's stock valued at $15,443,000 after buying an additional 80,014 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Trupanion by 2.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 306,752 shares of the financial services provider's stock worth $14,785,000 after buying an additional 6,338 shares during the last quarter.

Remove Ads

Trupanion Stock Down 5.2 %

NASDAQ TRUP traded down $1.98 on Friday, reaching $36.25. The company had a trading volume of 443,337 shares, compared to its average volume of 646,663. The company's fifty day moving average is $41.03 and its 200-day moving average is $46.55. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -157.61, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. On average, research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Fawwad Qureshi sold 1,373 shares of the company's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the transaction, the chief financial officer now owns 2,416 shares in the company, valued at approximately $82,675.52. This represents a 36.24 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the company's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $4,415,201.28. The trade was a 3.26 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 29,984 shares of company stock valued at $999,042 in the last 90 days. 5.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on TRUP shares. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Piper Sandler lowered their price objective on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $46.60.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.